Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-12 · accession 0001104659-25-014259 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-14 | 2025-02-12 | RYTM | Shulman Joseph | Chief Technical Off | S - Sale | $56.40 | -469 | 5,612 | -8% | -$26.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | S | D | 462 | $56.39 | 5,619 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-12 | S | D | 7 | $57.09 | 5,612 | D | — | — |